田振

发布时间:2013-06-13 16:20:40 作者: 浏览次数: 次

 

个人简介

田振,医学博士,副教授,多伦多大学医学院联合培养博士。研究方向为神经药理学,主要聚焦于情绪障碍性疾病(如抑郁症、焦虑症)及神经退行性疾病(如老年痴呆、帕金森症)的发病机制及潜在有效天然药物的筛选。主持国家及省部级课题多项,参与编写专著教材两部,在本领域期刊发表SCI论文三十余篇,获发明专利授权一项。

教育及工作经历

2006-2016年本硕博就读于第四军医大学药学/药理学专业,20166月获医学博士学位,毕业分配至解放军某部医院,授专业技术少校军衔,20211月入职西南大学药学院。

主持科研项目

1. 国家自然科学基金青年项目(818013292019.01-2021.12

2. 重庆市自然科学基金面上项目(cstc2021jcyj-msxmX06102021.09-2024.09

3. 重庆市教委科学研究项目(2021.09-2024.09

4. 基础药理教育部重点实验室项目(2023.11-2025.10

5. 中央高校基本业务经费项目(2022.01-2024.12

近两年发表论文

1. Mei-Feng Zhang, Jing-Hui Wang, Si Sun, Yi-Tong Xu , Dong Wan , Shan Feng, Zhen Tian*, Hui-Feng Zhu*. Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF-1α/CXCR4 pathway. Phytomedicine. 2024 Jan 15:128:155362.

2. Si Sun, Yitong Xu, Ningxi Yu, Meifeng Zhang, Jinghui Wang, Dong Wan, Zhen Tian*, Huifeng Zhu. Catalpol Alleviates Ischemic Stroke Through Promoting Angiogenesis and Facilitating Proliferation and Differentiation of Neural Stem Cells via the VEGF-A/KDR Pathway. Mol Neurobiol. 2023 Nov;60(11):6227-6247.

3. Zhen Tian#, Xin-Tong Lu, Xun Jiang, Jiao Tian. Bryostatin-1: a promising compound for neurological disorders. Front Pharmacol. 2023 Jun 7:14:1187411

4. Jia-Yi Yin, Xin-Tong Lu, Meng-Ling Hou, Ting Cao, Zhen Tian*. Sirtuin1-p53: A potential axis for cancer therapy. Biochem Pharmacol. 2023 Jun:212:115543.

5. Xin-Shang Wang, Yong-Li Jiang, Liang Lu, Ban Feng, Xue Ma, Kun Zhang, Shao-Yu Guan, Le Yang, Qing-Yu Fan, Xiao-Chen Zhu, Fan Yang, Jing-Yu Qi, Liu-Kun Yang, Xu-Bo Li, Ming-Gao Zhao, Wen Jiang, Zhen Tian* , Shui-Bing Liu*. Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice. Front Endocrinol. 2022 May 30:13:887238.

6. Zhen Tian#, Bin Feng, Xing-Qin Wang, Jiao Tian. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. Front Mol Neurosci. 2022 Nov 10:15:1030639.

7. Jiao Tian, Xing-Qin Wang, Zhen Tian*. Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials. Front Pharmacol. 2022 May 30:13:905898.


邮箱:zhentianzh@163.com,办公室:药化大楼906